Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05947760 · ClinicalTrials.gov registry record · Phase 4

Magnesium as an Adjuvant Agent for Postoperative Pain

A Phase 4 study of Pain, Postoperative, sponsored by University Hospitals Cleveland Medical Center.

Recruiting
Registry status
Phase 4
Development phase
64
Enrollment target
1
Study location

NCT05947760 is a Phase 4 study of Pain, Postoperative that is actively recruiting participants, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 64 participants, below the 272-participant average among 108 other Pain, Postoperative trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05947760, a Phase 4 study of Pain, Postoperative, is actively recruiting participants, sponsored by University Hospitals Cleveland Medical Center.

RECRUITING
Registry status
Phase 4
Development phase
64 participants
Enrollment target
1
Study location

Study Summary

Participants are being asked to participate in this research study because they have elected to undergo periacetabular osteotomy (PAO). This research study is looking at if using IV magnesium during surgery can help to reduce pain after surgery.

Conditions Studied

Interventions

  • DRUG IV Magnesium Sulfate

Study Locations (1)

Ohio

  • University Hospitals - Cleveland

Trial Details

FieldValue
Enrollment Target 64 participants
Start Date 2025-03-10
Est. Completion 2026-04-01
Phase Phase 4

What the Registry Record Tells You About NCT05947760

The ClinicalTrials.gov registry entry for NCT05947760 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 272-participant average among 108 other Pain, Postoperative trials with a reported enrollment target (76% lower). The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pain, Postoperative appearing as the primary indexed condition, and to 1 intervention - of which IV Magnesium Sulfate is the first listed.

NCT05947760 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT05947760 about?

NCT05947760 is a clinical study titled "Magnesium as an Adjuvant Agent for Postoperative Pain". Participants are being asked to participate in this research study because they have elected to undergo periacetabular osteotomy (PAO). This research study is looking at if using IV magnesium during surgery can help to reduce pain after surgery.

What is the current status of trial NCT05947760?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 64 participants. The study started on 2025-03-10. Estimated completion is 2026-04-01.

What conditions does trial NCT05947760 study?

This clinical trial studies the following conditions: Pain, Postoperative.

What interventions are being tested in trial NCT05947760?

The interventions under investigation include: IV Magnesium Sulfate (DRUG).

Who is sponsoring clinical trial NCT05947760?

This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05947760 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain, Postoperative

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.